The vehicle will be led by Shiprocket co-founder Vishesh Khurana, and early-stage investor Raj Snehil Juneja.
Policy & Regulations
Any decision taken at the EGM cannot be implemented until the next court hearing on March 13.
Other Asian manufacturers also aim to grab market share with auto show offerings.
India court refuses to stay BYJU's EGM to oust Raveendran but grants some relief to founder
Sinopharm-led consortium offers to take HK-listed China-TCM private in $3b deal
Mubadala reaches controlling stake in Brazilian food retailer Zamp
KKR kicks off process to divest stake in Indonesia-listed bread maker Nippon Indosari
Singapore-based PE firm Tower Capital Asia targets $500m for second fund
Tiktok Shop still violates govt regulations, says Indonesian minister
Our reporters track deals with a focus on Private Equity, Venture Capital and M&As across Southeast Asia, India and China, and bring it to your inbox every day.
At $50.5b, funds raised by startups in 2023 were down 5% year-on-year.
As global macroeconomic headwinds and continued geopolitical strife curtailed capital flows in 2023, both deal volume and value declined.
CVC Capital Partners Asia VI is 50% larger than its predecessor.
ESR's market value is currently down 67% since its stock price peaked in early 2021.
As of March 2023, KKR owns a 22.2% stake in the Sari Roti brand owner.
Novosol plans to expand across the Middle East and South Asia.
Existing investor Chiratae participated in the financing.
Alodokter issued Series C5 convertible preference shares worth $3.13m and $2.08m to HL Mando and Beacon VC respectively.
Investors including Prosus, General Atlantic, Peak XV say they are "deeply concerned about the stability of the company".
Rest of Asia
Zamp is in talks to operate Starbucks brand in Brazil.
The BharatGPT model will work in healthcare, governance, financial services, and education.
Talks are at an early stage and there's no certainty over the deal.
Currys owns 21 warehouses across the UK and Ireland, and 800 leasehold stores in 8 countries.
A $200m rights issue has been fully subscribed, BYJU's said.
The fund said it would invest in locally-listed companies working to boost their value.
Sinopharm already holds a 32.46% stake in China-TCM.
The amount flagged by SEBI was roughly 10 times higher than investigators had initially estimated.
Under the existing rules, it is voluntary to apply for ACCC approval in a merger.
Singapore-based Garden Impact Fund and Clarion Newlife Capital joined the funding round.